Literature DB >> 5115906

Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response.

R B Herberman, M E Oren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5115906

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Demonstration of cytotoxic antibodies in rabbits bearing tumors induced by Shope fibroma virus.

Authors:  S B Singh; J W Smith; W E Rawls; S S Tevethia
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

2.  A rapid method of following the spontaneous regression of experimental leukemias.

Authors:  I Ember; J Szöllösi; V Thomázy; I Arany; P Rády; P Kertai
Journal:  Experientia       Date:  1982-10-15

3.  Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.

Authors:  O Bakouche; D Gerlier
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

4.  Immune and natural antibodies to syngeneic murine plasma cell tumors.

Authors:  R B Herberman; T Aoki
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

5.  In vitro activation of cellular immune response to Gross virus-induced lymphoma.

Authors:  M Ortiz de Landazuri; R B Herberman
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

6.  Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system.

Authors:  H M Skurzak; E Klein; T O Yoshida; E W Lamon
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

7.  Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma.

Authors:  H L Ioachim; S E Keller; B H Dorsett; A Pearse
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

8.  Induction of antibody response to liposome-associated Gross-virus cell-surface antigen (GCSAa).

Authors:  D Gerlier; F Sakai; J F Doré
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.